GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: OMP-313M32
Compound class:
Antibody
Comment: Etigilimab (OMP-313M32) is an anti-TIGIT monoclonal antibody [1]. Blocking the TIGIT/PVR interaction is proposed to promote anti-tumour immunity. This mechanism is proposed to be used in conjunction with anti-PD/1/PD-L1 immuno-oncology therapeutics, to further enhance the anti-tumour immune response.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10742 | etigilimab |
Synonyms ![]() |
OMP-313M32 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 803 |
Other databases | |
Search PubMed clinical trials | etigilimab |
Search PubMed titles | etigilimab |
Search PubMed titles/abstracts | etigilimab |